Home » Authors » Nuala Moran

Articles by Nuala Moran

Ark Therapeutics' Gene Therapy Doubles Survival In Early Trial

April 11, 2001

UK Parliament Seeks Moratorium On Insurers' Use Of Genetic Tests

April 11, 2001

Nasdaq Buying Part Of Easdaq In Move That Helps Biotech Firms

April 4, 2001

Oxford Gene, Affymetrix Settle Microarray Patent Litigation

April 4, 2001

Nasdaq Buying Part Of Easdaq In Move That Helps Biotech Firms

April 4, 2001

Oxford Gene, Affymetrix Settle Microarray Patent Litigation

April 4, 2001

Proteome Sciences Establishing Proteomics Facility, Collaboration

March 28, 2001

Inpharmatica Gains Partner, Investment In Genentech Deal

March 28, 2001

Proteome Sciences Establishing Proteomics Facility, Collaboration

March 28, 2001

Inpharmatica Gains Partner, Investment In Genentech Deal

March 28, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.